Effectiveness of Tai Chi vs Cognitive Behavioural Therapy for Insomnia in Middle-Aged and Older Adults
November 27, 2025
Brand Name :
Sunosi
Synonyms :
solriamfetol
Class :
Norepinephrine/ Dopamine Reuptake Inhibitors
Dosage Forms & StrengthsÂ
Tablet Â
150mg Â
75mg Â
Upon awakening take 75mg orally everyday
The dose can be doubled at least every three days.
Maximum dose-150mg orally everyday
Upon awakening, take 37.5mg orally everyday
The dose can be doubled at least every three days.
Maximum dose-150mg orally everyday
Dose Adjustments
Dosage Modifications
Renal Impairment
Severe-Initiate 37.5mg everyday orally
Moderate- Initiate 37.5mg everyday orally
Mild-Dosage adjustment is not necessary
Safety & efficacy were not establishedÂ
Refer to the adult dosingÂ
it increases the toxicity of norepinephrine reuptake inhibitors
Norepinephrine Reuptake Inhibitors increase arrhythmia, causing the effect of dronedarone
it increases the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
it increases the effect of Norepinephrine Reuptake Inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
Norepinephrine Reuptake Inhibitors increase arrhythmia, causing the effect of dronedarone
it increases the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
it increases the effect of Norepinephrine Reuptake Inhibitors
it increases the toxicity of norepinephrine reuptake inhibitors
they increase the effect of Norepinephrine Reuptake Inhibitors
sympathomimetics increase the effect of hypertension of solriamfetol
sympathomimetics increase the effect of hypertension of solriamfetol
sympathomimetics increase the effect of hypertension of solriamfetol
sympathomimetics increase the effect of hypertension of solriamfetol
sympathomimetics increase the effect of hypertension of solriamfetol
may have an increased hypertensive effect when combined with hypertension agents
may have an increased hypertensive effect when combined with hypertension agents
may have an increased hypertensive effect when combined with hypertension agents
may have an increased hypertensive effect when combined with hypertension agents
may have an increased hypertensive effect when combined with hypertension agents
may have an increased hypertensive effect when combined with solriamfetol
may have an increased hypertensive effect when combined with solriamfetol
It may increase the hypertensive effect when combined with hypertension associated drugs
solriamfetol: they may increase the CNS depressant effect of CNS Depressants
solriamfetol: they may increase the CNS depressant effect of CNS Depressants
solriamfetol: they may increase the CNS depressant effect of CNS Depressants
solriamfetol: they may increase the CNS depressant effect of CNS Depressants
solriamfetol: they may increase the CNS depressant effect of CNS Depressants
side effects of dopamine agonists are increased with solriamfetol when combined
side effects of dopamine agonists are increased with solriamfetol when combined
side effects of dopamine agonists are increased with solriamfetol when combined
side effects of dopamine agonists are increased with solriamfetol when combined
side effects of dopamine agonists are increased with solriamfetol when combined
may increase the hypertension effects of solriamfetol
may increase the hypertension effects of solriamfetol
may increase the hypertension effects of solriamfetol
may increase the hypertension effects of solriamfetol erda
it increases the effect of hypertension in the case of hypertension-associated agents
it may increase the hypertensive effect of hypertension-associated agents
it increases the hypertensive effectiveness of agents associated with hypertension
it increases the effect of hypertension in hypertension-associated agents
it increases the concentration of Norepinephrine Reuptake Inhibitors
it increases the toxicity of Norepinephrine Reuptake Inhibitors
norepinephrine reuptake inhibitors decrease the effect of guanethidine
may increase the hypertension effect of sympathomimetic drugs
may increase the hypertensive effect of hypertension-associated agents
may increase the hypertensive effect
may increase the toxic effect of anti-Parkinson agents
may increase the hypertensive effect of hypertension-associated agents
it increases the concentration of Norepinephrine Reuptake Inhibitors
it increases the toxicity of Norepinephrine Reuptake Inhibitors
norepinephrine reuptake inhibitors decrease the effect of guanethidine
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
it increases the effect of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
they increase the metabolism of norepinephrine reuptake inhibitors
it increases the effect of norepinephrine reuptake inhibitors
Actions and spectrum:Â
solriamfetol is a wakefulness-promoting agent that acts by increasing the release of norepinephrine, dopamine, and histamine in the brain. It is used to treat the excessive daytime sleepiness with narcolepsy or obstructive sleep apnea.
solriamfetol helps improve wakefulness and reduce the frequency and severity of episodes of daytime sleepiness, thereby enhancing alertness and cognitive function.
It has a spectrum of action that primarily targets the central nervous system to combat sleepiness and improve daytime functioning in individuals with these sleep-related disorders.Â
Frequency definedÂ
1-10% (Narcolepsy)Â
Nausea (7%)Â
Insomnia (5%)Â
Constipation (3%)Â
Decreased appetite (9%)Â
Anxiety (6%)Â
Dry mouth (4%)Â
Palpitations (2%)Â Â
<2%Â
thoracic, mediastinal and Respiratory disorders: CoughÂ
General disorders: thirst, chest pain, Feeling jittery, chest discomfortÂ
Psychiatric disorders: bruxism, Agitation, irritabilityÂ
subcutaneous tissue and Skin disorders: HyperhidrosisÂ
Investigations: decreased Weight Â
>10% (Narcolepsy)Â
Headache (16%)Â Â
1-10% (OSA)Â
Decreased appetite (6%)Â
Diarrhea (4%)Â
Palpitations (3%)Â
Feeling jittery (3%)Â
Chest discomfort (2%)Â
Nausea (8%)Â
Anxiety (4%)Â
Irritability (3%)Â
Abdominal pain (3%)Â
Dizziness (2%)Â
Hyperhidrosis (2%)Â Â
<2%Â
Nervous system disorders: tremor, attention DisturbancesÂ
Gastrointestinal disorders: vomiting, ConstipationÂ
Psychiatric disorders: restlessness, BruxismÂ
Respiratory, mediastinal, and thoracic disorders: dyspnea, CoughÂ
Investigations: decreased Weight Â
Post marketing ReportsÂ
Hypersensitivity reactionsÂ
Black Box Warning:Â
There were no specific black box warnings associated with solriamfetol.Â
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Comorbidities:Â
Pregnancy consideration: pregnancy category: not assignedÂ
Lactation: Excreted in human breast milk: unknown Â
Pregnancy category:Â
Pharmacology:Â
solriamfetol’s exact mechanism of action is not known, but it is believed to work primarily through the inhibition of norepinephrine and dopamine reuptake transporters. By blocking the reuptake of neurotransmitters, it increases their levels in the brain, leading to enhanced wakefulness and alertness. solriamfetol increases the extracellular concentration of norepinephrine in certain areas of the brain involved in wakefulness and arousal. This contributes to the drug’s stimulating effects on the central nervous system. Â
Pharmacodynamics:Â
Pharmacokinetics:Â
AbsorptionÂ
After oral administration, solriamfetol is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are typically reached within 2 to 3 hours. The drug’s absorption is not significantly affected by food, so it can be taken with or without a meal.Â
DistributionÂ
solriamfetol has a high volume of distribution, that is widely distributed throughout the body’s tissues. It is primarily bound to plasma proteins, including albumin.Â
MetabolismÂ
solriamfetol undergoes extensive metabolism in the liver through enzymatic processes, primarily mediated by cytochrome P450 (CYP) enzymes, particularly CYP3A4 and CYP2C19. These enzymes convert solriamfetol into metabolites, which are further metabolized before being excreted.Â
Elimination and excretionÂ
The metabolites of solriamfetol are eliminated through the urine. A small portion of the dose is excreted unchanged in the urine as well. The drug’s elimination half-life is 7 to 8 hours.Â
Administration:Â
solriamfetol is typically administered orally in the form of tablets. The specific dosing regimen and administration instructions for solriamfetol may vary based on the individual’s condition and the healthcare provider’s recommendations. It is important to follow the prescribed dosage and administration instructions provided by the healthcare professional.Â
In general, solriamfetol can be taken with or without food. The dosing of solriamfetol is typically initiated at a lower dose and gradually titrated up to achieve the therapeutic effect and minimizing potential side effects. Dosage adjustments may also be necessary based on the individual’s response and tolerability.Â
Patient information leafletÂ
Generic Name: solriamfetolÂ
Pronounced: (soh-lee-ram-feh-tol)Â Â
Why do we use solriamfetol?Â
solriamfetol is a medication primarily used for the treatment of excessive sleepiness associated with narcolepsy, a neurological disorder characterized by sudden and uncontrollable bouts of sleepiness during the day. It helps to improve wakefulness and reduce the frequency and severity of daytime sleep episodes in individuals with narcolepsy.Â
Additionally, solriamfetol may also be used in the treatment of obstructive sleep apnea (OSA). It can help improve wakefulness and reduce the severity of daytime sleepiness in individuals with OSA.Â